nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomitapide—ABCB1—Lisinopril—systemic scleroderma	0.158	0.272	CbGbCtD
Lomitapide—ABCB1—Captopril—systemic scleroderma	0.118	0.203	CbGbCtD
Lomitapide—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0932	0.16	CbGbCtD
Lomitapide—ABCB1—Prednisone—systemic scleroderma	0.0745	0.128	CbGbCtD
Lomitapide—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0558	0.0959	CbGbCtD
Lomitapide—CYP3A4—Prednisone—systemic scleroderma	0.0446	0.0767	CbGbCtD
Lomitapide—ABCB1—Methotrexate—systemic scleroderma	0.0374	0.0642	CbGbCtD
Lomitapide—MTTP—Chylomicron-mediated lipid transport—HSPG2—systemic scleroderma	0.00965	0.383	CbGpPWpGaD
Lomitapide—MTTP—blood vessel—systemic scleroderma	0.00659	0.639	CbGeAlD
Lomitapide—MTTP—Lipoprotein metabolism—HSPG2—systemic scleroderma	0.00612	0.243	CbGpPWpGaD
Lomitapide—MTTP—Lipid and lipoprotein metabolism—HSPG2—systemic scleroderma	0.00407	0.162	CbGpPWpGaD
Lomitapide—MTTP—digestive system—systemic scleroderma	0.00244	0.237	CbGeAlD
Lomitapide—MTTP—Circadian rythm related genes—TOP1—systemic scleroderma	0.00206	0.0817	CbGpPWpGaD
Lomitapide—Decreased appetite—Captopril—systemic scleroderma	0.000681	0.00178	CcSEcCtD
Lomitapide—Malaise—Mycophenolic acid—systemic scleroderma	0.000681	0.00178	CcSEcCtD
Lomitapide—Malnutrition—Lisinopril—systemic scleroderma	0.00068	0.00178	CcSEcCtD
Lomitapide—Infection—Azathioprine—systemic scleroderma	0.000679	0.00178	CcSEcCtD
Lomitapide—Vertigo—Mycophenolic acid—systemic scleroderma	0.000678	0.00177	CcSEcCtD
Lomitapide—Urinary tract disorder—Mycophenolate mofetil—systemic scleroderma	0.000676	0.00177	CcSEcCtD
Lomitapide—Fatigue—Captopril—systemic scleroderma	0.000675	0.00177	CcSEcCtD
Lomitapide—Myalgia—Leflunomide—systemic scleroderma	0.000674	0.00176	CcSEcCtD
Lomitapide—Arthralgia—Leflunomide—systemic scleroderma	0.000674	0.00176	CcSEcCtD
Lomitapide—Chest pain—Leflunomide—systemic scleroderma	0.000674	0.00176	CcSEcCtD
Lomitapide—Connective tissue disorder—Mycophenolate mofetil—systemic scleroderma	0.000672	0.00176	CcSEcCtD
Lomitapide—Urethral disorder—Mycophenolate mofetil—systemic scleroderma	0.000671	0.00175	CcSEcCtD
Lomitapide—Constipation—Captopril—systemic scleroderma	0.00067	0.00175	CcSEcCtD
Lomitapide—Flatulence—Lisinopril—systemic scleroderma	0.00067	0.00175	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.000669	0.00175	CcSEcCtD
Lomitapide—Palpitations—Mycophenolic acid—systemic scleroderma	0.000667	0.00174	CcSEcCtD
Lomitapide—Discomfort—Leflunomide—systemic scleroderma	0.000665	0.00174	CcSEcCtD
Lomitapide—Skin disorder—Azathioprine—systemic scleroderma	0.000664	0.00174	CcSEcCtD
Lomitapide—Dry mouth—Leflunomide—systemic scleroderma	0.000659	0.00172	CcSEcCtD
Lomitapide—Back pain—Lisinopril—systemic scleroderma	0.000658	0.00172	CcSEcCtD
Lomitapide—Vomiting—Pentoxifylline—systemic scleroderma	0.000657	0.00172	CcSEcCtD
Lomitapide—Muscle spasms—Lisinopril—systemic scleroderma	0.000654	0.00171	CcSEcCtD
Lomitapide—Headache—Pentoxifylline—systemic scleroderma	0.000648	0.00169	CcSEcCtD
Lomitapide—Feeling abnormal—Captopril—systemic scleroderma	0.000646	0.00169	CcSEcCtD
Lomitapide—Arthralgia—Mycophenolic acid—systemic scleroderma	0.000643	0.00168	CcSEcCtD
Lomitapide—Chest pain—Mycophenolic acid—systemic scleroderma	0.000643	0.00168	CcSEcCtD
Lomitapide—Myalgia—Mycophenolic acid—systemic scleroderma	0.000643	0.00168	CcSEcCtD
Lomitapide—Infection—Leflunomide—systemic scleroderma	0.000641	0.00168	CcSEcCtD
Lomitapide—Gastrointestinal pain—Captopril—systemic scleroderma	0.000641	0.00167	CcSEcCtD
Lomitapide—Asthenia—Mometasone—systemic scleroderma	0.00064	0.00167	CcSEcCtD
Lomitapide—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.000639	0.00167	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.000638	0.00167	CcSEcCtD
Lomitapide—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.000635	0.00166	CcSEcCtD
Lomitapide—Discomfort—Mycophenolic acid—systemic scleroderma	0.000635	0.00166	CcSEcCtD
Lomitapide—Nervous system disorder—Leflunomide—systemic scleroderma	0.000633	0.00166	CcSEcCtD
Lomitapide—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000631	0.00165	CcSEcCtD
Lomitapide—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000628	0.00164	CcSEcCtD
Lomitapide—Anaemia—Lisinopril—systemic scleroderma	0.000628	0.00164	CcSEcCtD
Lomitapide—Skin disorder—Leflunomide—systemic scleroderma	0.000627	0.00164	CcSEcCtD
Lomitapide—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000624	0.00163	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000623	0.00163	CcSEcCtD
Lomitapide—Abdominal pain—Captopril—systemic scleroderma	0.000619	0.00162	CcSEcCtD
Lomitapide—Body temperature increased—Captopril—systemic scleroderma	0.000619	0.00162	CcSEcCtD
Lomitapide—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000617	0.00161	CcSEcCtD
Lomitapide—Dry skin—Prednisone—systemic scleroderma	0.000615	0.00161	CcSEcCtD
Lomitapide—Nausea—Pentoxifylline—systemic scleroderma	0.000614	0.00161	CcSEcCtD
Lomitapide—Chills—Mycophenolate mofetil—systemic scleroderma	0.000614	0.0016	CcSEcCtD
Lomitapide—Malaise—Lisinopril—systemic scleroderma	0.000613	0.0016	CcSEcCtD
Lomitapide—Infection—Mycophenolic acid—systemic scleroderma	0.000612	0.0016	CcSEcCtD
Lomitapide—Vertigo—Lisinopril—systemic scleroderma	0.000611	0.0016	CcSEcCtD
Lomitapide—Diarrhoea—Mometasone—systemic scleroderma	0.00061	0.0016	CcSEcCtD
Lomitapide—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000604	0.00158	CcSEcCtD
Lomitapide—Palpitations—Lisinopril—systemic scleroderma	0.000601	0.00157	CcSEcCtD
Lomitapide—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000598	0.00156	CcSEcCtD
Lomitapide—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000596	0.00156	CcSEcCtD
Lomitapide—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000595	0.00156	CcSEcCtD
Lomitapide—Alanine aminotransferase increased—Prednisone—systemic scleroderma	0.000591	0.00155	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00059	0.00154	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000588	0.00154	CcSEcCtD
Lomitapide—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000587	0.00153	CcSEcCtD
Lomitapide—Abdominal distension—Prednisone—systemic scleroderma	0.000583	0.00152	CcSEcCtD
Lomitapide—ABCB1—blood vessel—systemic scleroderma	0.000582	0.0564	CbGeAlD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	0.000582	0.0231	CbGpPWpGaD
Lomitapide—Paraesthesia—Leflunomide—systemic scleroderma	0.00058	0.00152	CcSEcCtD
Lomitapide—Chest pain—Lisinopril—systemic scleroderma	0.000579	0.00151	CcSEcCtD
Lomitapide—Arthralgia—Lisinopril—systemic scleroderma	0.000579	0.00151	CcSEcCtD
Lomitapide—Myalgia—Lisinopril—systemic scleroderma	0.000579	0.00151	CcSEcCtD
Lomitapide—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000576	0.00151	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000575	0.0015	CcSEcCtD
Lomitapide—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000573	0.0015	CcSEcCtD
Lomitapide—Discomfort—Lisinopril—systemic scleroderma	0.000572	0.00149	CcSEcCtD
Lomitapide—Dyspepsia—Leflunomide—systemic scleroderma	0.000568	0.00149	CcSEcCtD
Lomitapide—Vomiting—Mometasone—systemic scleroderma	0.000567	0.00148	CcSEcCtD
Lomitapide—Dry mouth—Lisinopril—systemic scleroderma	0.000566	0.00148	CcSEcCtD
Lomitapide—Feeling abnormal—Azathioprine—systemic scleroderma	0.000563	0.00147	CcSEcCtD
Lomitapide—Asthenia—Captopril—systemic scleroderma	0.000562	0.00147	CcSEcCtD
Lomitapide—Decreased appetite—Leflunomide—systemic scleroderma	0.000561	0.00147	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000561	0.00147	CcSEcCtD
Lomitapide—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000559	0.00146	CcSEcCtD
Lomitapide—Headache—Mometasone—systemic scleroderma	0.000559	0.00146	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000557	0.00146	CcSEcCtD
Lomitapide—Fatigue—Leflunomide—systemic scleroderma	0.000557	0.00146	CcSEcCtD
Lomitapide—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000553	0.00145	CcSEcCtD
Lomitapide—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000553	0.00144	CcSEcCtD
Lomitapide—Constipation—Leflunomide—systemic scleroderma	0.000552	0.00144	CcSEcCtD
Lomitapide—Infection—Lisinopril—systemic scleroderma	0.000551	0.00144	CcSEcCtD
Lomitapide—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000551	0.00144	CcSEcCtD
Lomitapide—Somnolence—Mycophenolic acid—systemic scleroderma	0.000548	0.00143	CcSEcCtD
Lomitapide—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000542	0.00142	CcSEcCtD
Lomitapide—Abdominal pain—Azathioprine—systemic scleroderma	0.00054	0.00141	CcSEcCtD
Lomitapide—Body temperature increased—Azathioprine—systemic scleroderma	0.00054	0.00141	CcSEcCtD
Lomitapide—Skin disorder—Lisinopril—systemic scleroderma	0.000539	0.00141	CcSEcCtD
Lomitapide—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000537	0.0014	CcSEcCtD
Lomitapide—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000536	0.0014	CcSEcCtD
Lomitapide—Diarrhoea—Captopril—systemic scleroderma	0.000536	0.0014	CcSEcCtD
Lomitapide—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000535	0.0014	CcSEcCtD
Lomitapide—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000535	0.0014	CcSEcCtD
Lomitapide—Feeling abnormal—Leflunomide—systemic scleroderma	0.000532	0.00139	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000532	0.00139	CcSEcCtD
Lomitapide—Fatigue—Mycophenolic acid—systemic scleroderma	0.000531	0.00139	CcSEcCtD
Lomitapide—Nausea—Mometasone—systemic scleroderma	0.00053	0.00138	CcSEcCtD
Lomitapide—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000528	0.00138	CcSEcCtD
Lomitapide—Constipation—Mycophenolic acid—systemic scleroderma	0.000527	0.00138	CcSEcCtD
Lomitapide—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000526	0.00138	CcSEcCtD
Lomitapide—Weight decreased—Prednisone—systemic scleroderma	0.000524	0.00137	CcSEcCtD
Lomitapide—Dizziness—Captopril—systemic scleroderma	0.000518	0.00135	CcSEcCtD
Lomitapide—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000517	0.00135	CcSEcCtD
Lomitapide—Abdominal pain—Leflunomide—systemic scleroderma	0.00051	0.00133	CcSEcCtD
Lomitapide—Body temperature increased—Leflunomide—systemic scleroderma	0.00051	0.00133	CcSEcCtD
Lomitapide—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000508	0.00133	CcSEcCtD
Lomitapide—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000507	0.00133	CcSEcCtD
Lomitapide—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000507	0.00133	CcSEcCtD
Lomitapide—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000507	0.00133	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000505	0.00132	CcSEcCtD
Lomitapide—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000504	0.00132	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000504	0.00132	CcSEcCtD
Lomitapide—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000501	0.00131	CcSEcCtD
Lomitapide—Paraesthesia—Lisinopril—systemic scleroderma	0.000498	0.0013	CcSEcCtD
Lomitapide—Vomiting—Captopril—systemic scleroderma	0.000498	0.0013	CcSEcCtD
Lomitapide—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000496	0.0013	CcSEcCtD
Lomitapide—Somnolence—Lisinopril—systemic scleroderma	0.000493	0.00129	CcSEcCtD
Lomitapide—Headache—Captopril—systemic scleroderma	0.000491	0.00128	CcSEcCtD
Lomitapide—Dyspepsia—Lisinopril—systemic scleroderma	0.000488	0.00128	CcSEcCtD
Lomitapide—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000487	0.00127	CcSEcCtD
Lomitapide—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000487	0.00127	CcSEcCtD
Lomitapide—Infection—Mycophenolate mofetil—systemic scleroderma	0.000483	0.00126	CcSEcCtD
Lomitapide—Decreased appetite—Lisinopril—systemic scleroderma	0.000482	0.00126	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000479	0.00125	CcSEcCtD
Lomitapide—Fatigue—Lisinopril—systemic scleroderma	0.000478	0.00125	CcSEcCtD
Lomitapide—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000477	0.00125	CcSEcCtD
Lomitapide—Constipation—Lisinopril—systemic scleroderma	0.000474	0.00124	CcSEcCtD
Lomitapide—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000472	0.00123	CcSEcCtD
Lomitapide—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00047	0.00123	CcSEcCtD
Lomitapide—Diarrhoea—Azathioprine—systemic scleroderma	0.000468	0.00122	CcSEcCtD
Lomitapide—Nausea—Captopril—systemic scleroderma	0.000465	0.00122	CcSEcCtD
Lomitapide—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000464	0.00121	CcSEcCtD
Lomitapide—Asthenia—Leflunomide—systemic scleroderma	0.000463	0.00121	CcSEcCtD
Lomitapide—Feeling abnormal—Lisinopril—systemic scleroderma	0.000457	0.0012	CcSEcCtD
Lomitapide—Connective tissue disorder—Prednisone—systemic scleroderma	0.000456	0.00119	CcSEcCtD
Lomitapide—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000454	0.00119	CcSEcCtD
Lomitapide—Dizziness—Azathioprine—systemic scleroderma	0.000452	0.00118	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000443	0.00116	CcSEcCtD
Lomitapide—Asthenia—Mycophenolic acid—systemic scleroderma	0.000442	0.00116	CcSEcCtD
Lomitapide—Diarrhoea—Leflunomide—systemic scleroderma	0.000442	0.00115	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	0.000441	0.0175	CbGpPWpGaD
Lomitapide—Abdominal pain—Lisinopril—systemic scleroderma	0.000439	0.00115	CcSEcCtD
Lomitapide—Body temperature increased—Lisinopril—systemic scleroderma	0.000439	0.00115	CcSEcCtD
Lomitapide—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000437	0.00114	CcSEcCtD
Lomitapide—Vomiting—Azathioprine—systemic scleroderma	0.000435	0.00114	CcSEcCtD
Lomitapide—Eye disorder—Prednisone—systemic scleroderma	0.000433	0.00113	CcSEcCtD
Lomitapide—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000432	0.00113	CcSEcCtD
Lomitapide—Infestation NOS—Methotrexate—systemic scleroderma	0.000432	0.00113	CcSEcCtD
Lomitapide—Infestation—Methotrexate—systemic scleroderma	0.000432	0.00113	CcSEcCtD
Lomitapide—Headache—Azathioprine—systemic scleroderma	0.000428	0.00112	CcSEcCtD
Lomitapide—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000428	0.00112	CcSEcCtD
Lomitapide—Dizziness—Leflunomide—systemic scleroderma	0.000427	0.00112	CcSEcCtD
Lomitapide—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000423	0.0011	CcSEcCtD
Lomitapide—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000421	0.0011	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00042	0.0011	CcSEcCtD
Lomitapide—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000416	0.00109	CcSEcCtD
Lomitapide—Haematuria—Methotrexate—systemic scleroderma	0.000412	0.00108	CcSEcCtD
Lomitapide—Vomiting—Leflunomide—systemic scleroderma	0.000411	0.00107	CcSEcCtD
Lomitapide—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000408	0.00107	CcSEcCtD
Lomitapide—Dizziness—Mycophenolic acid—systemic scleroderma	0.000407	0.00106	CcSEcCtD
Lomitapide—Nausea—Azathioprine—systemic scleroderma	0.000406	0.00106	CcSEcCtD
Lomitapide—Headache—Leflunomide—systemic scleroderma	0.000404	0.00106	CcSEcCtD
Lomitapide—Malnutrition—Prednisone—systemic scleroderma	0.000404	0.00106	CcSEcCtD
Lomitapide—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000401	0.00105	CcSEcCtD
Lomitapide—Asthenia—Lisinopril—systemic scleroderma	0.000398	0.00104	CcSEcCtD
Lomitapide—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000398	0.00104	CcSEcCtD
Lomitapide—Vomiting—Mycophenolic acid—systemic scleroderma	0.000392	0.00102	CcSEcCtD
Lomitapide—Headache—Mycophenolic acid—systemic scleroderma	0.000386	0.00101	CcSEcCtD
Lomitapide—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000384	0.001	CcSEcCtD
Lomitapide—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000384	0.001	CcSEcCtD
Lomitapide—Nausea—Leflunomide—systemic scleroderma	0.000384	0.001	CcSEcCtD
Lomitapide—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000383	0.001	CcSEcCtD
Lomitapide—Urethral disorder—Methotrexate—systemic scleroderma	0.00038	0.000993	CcSEcCtD
Lomitapide—Diarrhoea—Lisinopril—systemic scleroderma	0.00038	0.000992	CcSEcCtD
Lomitapide—Ill-defined disorder—Prednisone—systemic scleroderma	0.000375	0.000979	CcSEcCtD
Lomitapide—Anaemia—Prednisone—systemic scleroderma	0.000373	0.000975	CcSEcCtD
Lomitapide—Dizziness—Lisinopril—systemic scleroderma	0.000367	0.000959	CcSEcCtD
Lomitapide—Nausea—Mycophenolic acid—systemic scleroderma	0.000366	0.000956	CcSEcCtD
Lomitapide—Malaise—Prednisone—systemic scleroderma	0.000364	0.000952	CcSEcCtD
Lomitapide—Vertigo—Prednisone—systemic scleroderma	0.000363	0.000948	CcSEcCtD
Lomitapide—Eye disorder—Methotrexate—systemic scleroderma	0.000362	0.000947	CcSEcCtD
Lomitapide—Cardiac disorder—Methotrexate—systemic scleroderma	0.00036	0.00094	CcSEcCtD
Lomitapide—Vomiting—Lisinopril—systemic scleroderma	0.000353	0.000922	CcSEcCtD
Lomitapide—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000349	0.000913	CcSEcCtD
Lomitapide—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000349	0.000912	CcSEcCtD
Lomitapide—Chills—Methotrexate—systemic scleroderma	0.000348	0.000909	CcSEcCtD
Lomitapide—Headache—Lisinopril—systemic scleroderma	0.000348	0.000909	CcSEcCtD
Lomitapide—Myalgia—Prednisone—systemic scleroderma	0.000344	0.000898	CcSEcCtD
Lomitapide—Arthralgia—Prednisone—systemic scleroderma	0.000344	0.000898	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000341	0.000892	CcSEcCtD
Lomitapide—Discomfort—Prednisone—systemic scleroderma	0.00034	0.000888	CcSEcCtD
Lomitapide—Malnutrition—Methotrexate—systemic scleroderma	0.000337	0.000882	CcSEcCtD
Lomitapide—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000333	0.000869	CcSEcCtD
Lomitapide—Nausea—Lisinopril—systemic scleroderma	0.00033	0.000861	CcSEcCtD
Lomitapide—Infection—Prednisone—systemic scleroderma	0.000327	0.000856	CcSEcCtD
Lomitapide—Back pain—Methotrexate—systemic scleroderma	0.000326	0.000853	CcSEcCtD
Lomitapide—Nervous system disorder—Prednisone—systemic scleroderma	0.000323	0.000845	CcSEcCtD
Lomitapide—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000321	0.00084	CcSEcCtD
Lomitapide—Skin disorder—Prednisone—systemic scleroderma	0.00032	0.000837	CcSEcCtD
Lomitapide—Hyperhidrosis—Prednisone—systemic scleroderma	0.000319	0.000833	CcSEcCtD
Lomitapide—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000313	0.000818	CcSEcCtD
Lomitapide—Anaemia—Methotrexate—systemic scleroderma	0.000312	0.000815	CcSEcCtD
Lomitapide—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000309	0.000808	CcSEcCtD
Lomitapide—CYP3A4—digestive system—systemic scleroderma	0.000305	0.0295	CbGeAlD
Lomitapide—Headache—Mycophenolate mofetil—systemic scleroderma	0.000305	0.000796	CcSEcCtD
Lomitapide—Malaise—Methotrexate—systemic scleroderma	0.000304	0.000795	CcSEcCtD
Lomitapide—Vertigo—Methotrexate—systemic scleroderma	0.000303	0.000792	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.0003	0.000785	CcSEcCtD
Lomitapide—Paraesthesia—Prednisone—systemic scleroderma	0.000296	0.000773	CcSEcCtD
Lomitapide—Dyspepsia—Prednisone—systemic scleroderma	0.00029	0.000758	CcSEcCtD
Lomitapide—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000289	0.000755	CcSEcCtD
Lomitapide—Chest pain—Methotrexate—systemic scleroderma	0.000287	0.000751	CcSEcCtD
Lomitapide—Myalgia—Methotrexate—systemic scleroderma	0.000287	0.000751	CcSEcCtD
Lomitapide—Arthralgia—Methotrexate—systemic scleroderma	0.000287	0.000751	CcSEcCtD
Lomitapide—Decreased appetite—Prednisone—systemic scleroderma	0.000286	0.000749	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000285	0.000746	CcSEcCtD
Lomitapide—Fatigue—Prednisone—systemic scleroderma	0.000284	0.000743	CcSEcCtD
Lomitapide—Discomfort—Methotrexate—systemic scleroderma	0.000284	0.000742	CcSEcCtD
Lomitapide—Constipation—Prednisone—systemic scleroderma	0.000282	0.000737	CcSEcCtD
Lomitapide—Infection—Methotrexate—systemic scleroderma	0.000274	0.000715	CcSEcCtD
Lomitapide—Feeling abnormal—Prednisone—systemic scleroderma	0.000272	0.00071	CcSEcCtD
Lomitapide—Nervous system disorder—Methotrexate—systemic scleroderma	0.00027	0.000706	CcSEcCtD
Lomitapide—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000269	0.000704	CcSEcCtD
Lomitapide—Skin disorder—Methotrexate—systemic scleroderma	0.000267	0.000699	CcSEcCtD
Lomitapide—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000266	0.000696	CcSEcCtD
Lomitapide—ABCB1—Allograft Rejection—IL13—systemic scleroderma	0.000264	0.0105	CbGpPWpGaD
Lomitapide—Abdominal pain—Prednisone—systemic scleroderma	0.00026	0.000681	CcSEcCtD
Lomitapide—Body temperature increased—Prednisone—systemic scleroderma	0.00026	0.000681	CcSEcCtD
Lomitapide—MTTP—Metabolism—HSPG2—systemic scleroderma	0.000259	0.0103	CbGpPWpGaD
Lomitapide—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000251	0.000656	CcSEcCtD
Lomitapide—Paraesthesia—Methotrexate—systemic scleroderma	0.000247	0.000646	CcSEcCtD
Lomitapide—Somnolence—Methotrexate—systemic scleroderma	0.000245	0.00064	CcSEcCtD
Lomitapide—Dyspepsia—Methotrexate—systemic scleroderma	0.000242	0.000634	CcSEcCtD
Lomitapide—Decreased appetite—Methotrexate—systemic scleroderma	0.000239	0.000626	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000238	0.000621	CcSEcCtD
Lomitapide—Fatigue—Methotrexate—systemic scleroderma	0.000237	0.000621	CcSEcCtD
Lomitapide—Asthenia—Prednisone—systemic scleroderma	0.000236	0.000618	CcSEcCtD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—systemic scleroderma	0.000234	0.00932	CbGpPWpGaD
Lomitapide—Feeling abnormal—Methotrexate—systemic scleroderma	0.000227	0.000593	CcSEcCtD
Lomitapide—Diarrhoea—Prednisone—systemic scleroderma	0.000225	0.000589	CcSEcCtD
Lomitapide—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000225	0.000589	CcSEcCtD
Lomitapide—Dizziness—Prednisone—systemic scleroderma	0.000218	0.00057	CcSEcCtD
Lomitapide—Abdominal pain—Methotrexate—systemic scleroderma	0.000218	0.000569	CcSEcCtD
Lomitapide—Body temperature increased—Methotrexate—systemic scleroderma	0.000218	0.000569	CcSEcCtD
Lomitapide—ABCB1—digestive system—systemic scleroderma	0.000216	0.0209	CbGeAlD
Lomitapide—ABCB1—Allograft Rejection—CTLA4—systemic scleroderma	0.000212	0.00845	CbGpPWpGaD
Lomitapide—Vomiting—Prednisone—systemic scleroderma	0.00021	0.000548	CcSEcCtD
Lomitapide—Headache—Prednisone—systemic scleroderma	0.000206	0.00054	CcSEcCtD
Lomitapide—Asthenia—Methotrexate—systemic scleroderma	0.000198	0.000516	CcSEcCtD
Lomitapide—MTTP—Metabolism—CTGF—systemic scleroderma	0.000196	0.0078	CbGpPWpGaD
Lomitapide—Nausea—Prednisone—systemic scleroderma	0.000196	0.000512	CcSEcCtD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—EDN1—systemic scleroderma	0.000193	0.00767	CbGpPWpGaD
Lomitapide—Diarrhoea—Methotrexate—systemic scleroderma	0.000188	0.000493	CcSEcCtD
Lomitapide—Dizziness—Methotrexate—systemic scleroderma	0.000182	0.000476	CcSEcCtD
Lomitapide—ABCB1—lung—systemic scleroderma	0.00018	0.0174	CbGeAlD
Lomitapide—Vomiting—Methotrexate—systemic scleroderma	0.000175	0.000458	CcSEcCtD
Lomitapide—ABCB1—Allograft Rejection—HLA-DQB1—systemic scleroderma	0.000175	0.00696	CbGpPWpGaD
Lomitapide—Headache—Methotrexate—systemic scleroderma	0.000173	0.000451	CcSEcCtD
Lomitapide—ABCB1—Allograft Rejection—IL1A—systemic scleroderma	0.000166	0.00661	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CD40LG—systemic scleroderma	0.000165	0.00657	CbGpPWpGaD
Lomitapide—Nausea—Methotrexate—systemic scleroderma	0.000164	0.000428	CcSEcCtD
Lomitapide—ABCB1—Allograft Rejection—IL1B—systemic scleroderma	8.67e-05	0.00345	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—NOS3—systemic scleroderma	8.54e-05	0.0034	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—TGFB1—systemic scleroderma	6.73e-05	0.00268	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	3.32e-05	0.00132	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—HSPG2—systemic scleroderma	2.83e-05	0.00113	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CTGF—systemic scleroderma	2.15e-05	0.000854	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—HSPG2—systemic scleroderma	1.75e-05	0.000694	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CTGF—systemic scleroderma	1.32e-05	0.000526	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—NOS3—systemic scleroderma	9.35e-06	0.000372	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—NOS3—systemic scleroderma	5.76e-06	0.000229	CbGpPWpGaD
